NextGen Omics & Data 2025 Logo - No Padding

13 - 14 November 2025 | London, UK

Bringing together 1000+ key scientific researchers, pharma representatives, & healthcare leaders under one roof to accelerate omics research across therapeutic areas through our NGS & Clinical Diagnostics; Multi-Omics in Single Cell and Spatial Analysis; NextGen Omics Data & Analysis; & Liquid Biopsies programmes

United In Purpose: Where Omics Meets Data Analysis

Together we can accelerate life-saving treatments with innovation and precision.

NextGen Omics & Data 2025 is the meeting point across omics research, uniting four longstanding communities on one platform.
Through this event, we enable industry, academic, and healthcare experts to build partnerships, align specialisms, bridge unknowns and drive innovations that change our understanding of health and disease.

Hear from past attendees of last year's NextGen Omics 2024 conference

Overview NGS & Clinical Diagnostics Multi-Omics in Single Cell & Spatial Analysis NextGen Omics Data & Analysis Liquid Biopsies

Welcome to NextGen Omics & Data 2025, Oxford Global’s 4-in-1 Flagship Multi-Omics Meeting

Bringing together key scientific leaders representing renowned pharmaceutical organisations as well as academic & healthcare institutions to discuss the latest scientific & technological advancements across a two-day programme delving into the latest innovations across the omics field, including data management, clinical genomics, and spatial imaging.

Our combined agenda which includes our brand new NextGen Omics Data & Analysis programme offers a one-stop-shop platform for multi-omics approaches via cutting edge presentations and diverse interactive sessions, bridging the gap between fundamental omics research and & its applications in drug development & diagnostics. Do not miss out on experiencing leading-edge science to stay ahead of upcoming breakthroughs predicted to impact the next-generation omics market. 

NextGen Omics 2025

  • Hear from and meet with the key innovators in multi-omics. 2024 attendees included: Senior Director, Bioinformatics; Astex; Executive Director, Computational Biology, Sanofi; Director, NGS/ Transcriptomics, AstraZeneca
  • Discuss the advancements in clinical genomics. Presentations will include applying genome sequencing to disease prevention, reproducibility & validation of variants, real world clinical applications and metagenomics analysis developments
  • Engage in thought-provoking panel discussions, roundtables & workshops on topics including Genomic Approaches For Diagnosing Patients With Rare Diseases; Multi-Omics & It’s Clinical Application; and The Role of Multi-Omics In Advancing Precision Therapeutics

Agenda at a Glance


Day One

Track 1: Clinical Genomics
Track 2: Multi-Omics for Precision Medicine  

Day Two

Track 1: Advanced Sequencing Technologies for Clinical Diagnostics 
Track 2: Genomic Sequencing & Screening in Hospitals

Multi-Omics in Single Cell & Spatial Analysis 2025

  • Hear from and meet with the key innovators in single cell & spatial biology. 2024 attendees included, Director of Computational Biology, Director of Bioinformatics, NGS & Transcriptomics & Professor of Computational Genomics
  • New to 2025! Advance your understanding emerging of single cell technologies from novel technologies for single cell imaging, through to one pot assays, benchmarking single cell technologies and updates from single cell multi-omics, applying omics in the clinic, bioinformatics for single cell analysis and clinical genomics update
  • Discuss the latest innovations in spatial multi-omics tools, techniques & approaches and learn how it is poised to fuel the next wave of biomedical innovation. Presentations will delve into translating spatial imaging techniques & approaches into the clinic, multi-modality processing and case studies from various spatial multi-omics
  • New to 2025! Gain comprehensive insights into utilising spatial biology in pharma. Hear how Spatial Biology is driving forward biomarker and drug target discovery as well as diagnostic and therapeutic innovation with its impact on disease research and ability to enable a tailored precision medicine approach

Agenda at a Glance


Day One

Track 3: Advanced Single Cell Technologies
Track 4:
Spatial Biology in Clinical Development
Track 5: 
Spatial Multi-Omics in Drug Discovery

Day Two

Track 3: Single Cell & Spatial Analysis: Proteomics & Metabolomics
Track 4:
Single Cell in Translational Drug Development

NextGen Omics Data & Analysis

  • Hear from & meet with the key innovators in omic data analysis. 2025 speakers include, Director, Digital Science & Innovation; Director, Computational Biology; Director, Saftey Innovation & PROTAC Science; and Director, Discovery Omics
  • New to 2025! Take a deep dive into data harmonisation, integration and analysis. Presentations will include tools for analysing high-throughput sequencing data, large-scale data analysis and AI/ML toolkits for multi-omic datasets
  • New to 2025! Dive deeper into advances in big data, with a large focus on ensuring FAIR data principals with multi-omic datasets and how to integrate omics technologies into large data projects
  • Overcome the research challenges you face. Learn how experts are overcoming barriers in acquiring and analysing spatial data and how they are navigating the computational complexities of processing and turning datasets into understandable interpretable knowledge

Agenda at a Glance


Day One:

Track 6: Multi-Omics Approaches for Data Integration, Harmonisation & Analytics

Track 7: Digital Transformation Of Omics With FAIR Data

Day Two:

Track 5: Advances In Omics & Big Data

Track 6: Single Cell & Spatial Analysis - AI-Guided Multi Omic Data Integration, Harmonisation & Analytics

7th Annual Liquid Biopsies Congress

  • Hear from and meet with the key innovators in liquid biopsies. 2024 attendees included, Chief Scientific Officer; Executive Director, Translational Medicine; Consultant Medical Oncologist; and Distinguished Research Professor of Clinical Chemistry
  • New to 2025! Advance your understanding emerging of innovations in Liquid Biopsy in Precision Oncology from implementations in clinical trials, integrative technologies across omics, and advancements in our understanding of ctDNA
  • New to 2025! Take a deep dive into the use of Liquid Biopsies in targeted gene therapy. Presentations will explore the role of liquid biopsies for targeted treatments and mutation analysis
  • Gain comprehensive insights into utilising liquid biopsies in pharma. Hear from key opinion leaders across the pharmaceutical industry, all utilising liquid biopsies to advance their R&D pipelines

Agenda at a Glance


Day One:

Track 8: Liquid Biopsy Innovations

Day Two:

Track 7: Applications to Targeted Gene Therapy

Key Themes

Industry experts shared their insights on the breakthroughs set to drive the next wave of precision medicine. Multi-omics integration is transforming our understanding of disease, expanding beyond oncology to chronic conditions. AI/ML are unlocking insights from complex data, while spatial transcriptomics is redefining tissue analysis. In situ multi-omics, including transcriptomics, DNA, and protein sequencing, is offering deeper biological insights. Collaborative data platforms are accelerating discoveries, driving innovation and collaboration at an unprecedented pace. The future of precision medicine is unfolding now—let’s shape its impact!

NextGen Biomed 2025

Advancing Therapeutic Innovation Through Multi-Omics Research  

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. 

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

Hear from past attendees of last year's Biologics 2024 conference

Explore the NextGen Omics & Spatial Biology US 2025 Programme

Antibody Society

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society

What to Expect at NextGen Omics & Data 2025

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative program there are over 700 pre-arranged 1-2-1 meetings and over 12 hours of networking solutions. Don't miss the opportunity to connect with 1000 leaders from across pharma, biotech, regulatory and academia.

Engaging Thought Leadership
Experience a variety of interactive discussions, thought leadership debated, & collaborative roundtables, with insights from industry leaders on key developments and pain points in the advancement of multi-omics.

Global Technology Showcase
An international exhibition showcasing cutting-edge technologies & services from premier providers in the scientific field.

Networking Emphasis
Unparalleled networking opportunities, including personalised 1-2-1 meetings, a vibrant drinks reception, and informal gatherings to foster meaningful connections.

NextGen Biomed - What to Expect Exhibiting 2
NextGen Biomed - What to Expect Exhibiting 3
NextGen Biomed - What to Expect Poster 2
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments

NextGen Multi-Omics 2025 Programme Highlights

Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:

NGS, CLINICAL OMICS & DIAGNOSTICS 
Panel Discussion: Overcoming Multi-Omics Data Harmonisation & Analysis Challenges 

Moderator: Ruslan Sadreyev, Director of Bioinformatics & Assistant Professor, Massachusetts General Hospital 
Panellists: Aridaman Pandit, Senior Principal Research Scientist, Abbvie; Felix Francis, Sr. Manager, Data Management and Analytics Technology Lead, Takeda; Luca Pinello, Associate Professor of Pathology, Harvard Medical School 

NGS, CLINICAL OMICS & DIAGNOSTICS
Presentation: An Update On Global Genomics & Diagnostics Policy  

Presented by: Virginia Acha, AVP Global Regulatory Policy & Intelligence, MSD

SINGLE CELL 
Panel Discussion: Single Cell Multi-Omics Integration – From The Pharma Perspective 

Panellists: Tao Yang, Director of Computational Biology, Eli Lilly 

SPATIAL MULTI-OMICS
Roundtable Discussion: Safety Biomarkers in the age of Spatial Biology    

Moderator: Marina Bleck, Principal Scientist, Boehringer Ingelheim 

SPATIAL MULTI-OMICS 
Workshop: Spatial Genomics & Transcriptomics to Investigate Tumor Biology  Chronic Disease Immunotherapies?

Two presentations followed by a panel discussion with insights from Yasser Riazalhosseini, Associate Professor & Head of Cancer Genomics, McGill University 
Stephen Wong, Department Chair & Centre Director Houston Methodist Hospital, Professor at Cornell Medical College 

Speakers

Key Speakers of NextGen Omics 2024 Included:

Meet Our Expert Speakers

NextGen Omics & Data 2025 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Basel Abu- Jamous
Director,
Nucleome Therapeutics
Darren Hodgson
Executive Director,
AstraZeneca
Demetra Georgiou
Chair,
Incisive Health
Emma Huang
Head of Data Sciences,
Engitix
Harpreet Saini
Senior Director,
Astex Pharmaceuticals
Joke Reumers
Director Discovery Omics,
Janssen R&D, LLC
Junmei Cairns
Associate Director,
AstraZeneca
Krishna Chatterjee
Director, NIHR CCRC, Professor, Endocrinology Inherited Thyroid Disorders,
The ALBORADA DDI, University of Cambridge
Mirjana Efremova
Senior Lecturer & Group Leader,
Barts Cancer Institute
Olukayode Sosina
Manager, Statistical Geneticist,
Regeneron
Remco Loos
Senior Director,
Bristol Myers Squibb
Sumeet Pandey
Associate Director, Single Cell Translational Scientist,
GSK
Alessandro Bonetti
Associate Principal Scientist,
AstraZeneca
Alex Frankell
Group Leader,
University of Cambridge
Diana Barelle
Professor of Genomic Medicine,
soton.ac.uk
Dominic Rothwell
Deputy Director,
Cancer Research UK Manchester Institute
Emma Sutcliffe
Chief Patient Officer,
ISPEP
Fernando Calero
Associate Principal Scientist,
AstraZeneca
James Schofield
CEO,
TopMD Precision Medicine Ltd
Jan-Philipp Mallm
Principal Investigator,
Dkfz-Heidelberg
Kevin Moreau
Director Safety Innovation,
AstraZeneca
Marco Mina
Director, Computational Biology,
Haya Therapeutics
Matthew Cobb
Professor of Zoology,
University of Manchester
Philip Beer
Chief Medical Officer,
Step Pharma
Stefano Pirrò
Computational Scientist,
GSK
Van Zyl Engelbrecht
Head of Country Operations,
Alexion Pharmaceuticals
Vinay Pawar
Director, Digital Science & Innovation,
Novo Nordisk AS

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Sponsors

Interested in Sponsoring NextGen Omics & Data 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Multi-Omics offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of medicine today.

New Opportunities

The Start-up Zone

Are you developing a cutting-edge therapy, platform or technology? Our Start-Up Zone is designed to support emerging companies looking to increase their visibility, find potential partners or early adopters, and meet their investment goals – connecting them with our community of pharma, investors, and mid-to-large size biotechs. 

Located in the Exhibition Hall, the Start-Up Zone allows therapeutic pioneers to showcase their approach, conduct invaluable 1:1 meetings and deliver a quick-fire pitch.

We offer two options starting from £1500 (+VAT), based on the size of your organisation. To get involved, apply today and our Start-Up Lead will be in touch to discuss further.

Criteria:

The Start-Up Zone is designed for therapeutic start-ups, academic spin-outs, and early-stage technology/service providers.

To be eligible for inclusion, you must meet the following criteria:

•    0 – 5 years operating
•    0 – 30 employees
•    Pre-Series A funding

Successful applicants will receive as part of their package:

•    1 full conference pass
•    10-minute pitch on the Start-Up Stage
•    1x1m space in Start-Up Zone: cocktail table provided, start-up to bring 1x pull-up banner
•    Logo featured on website & event platform as a participating start-up
•    Ability to arrange 1:1 meetings via to the congress app

2025 Young Scientist Awards (YSA) for Best Poster Presentation

The NextGen Biomed Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.

Please submit your poster presentation by no later than 13th January 2025 in the below category:

  • Protein/Antibody Engineering
  • Bioanalysis & Characterisation
  • Next Generation Biotherapeutics
  • Peptides Chemistry & Therapeutics
  • Oligonucleotides Chemistry & Therapeutics
  • Sustainable Chemistry & Manufacturing
  • Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
  • Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
  • ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA

Applicants must follow the procedure as follows: 

  • Register and submit an abstract by 13th January 2025 using the registration link to the left on this page 
  • Once registered you will be provided with the online abstract submission form 
  • Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.) 
  • The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event 
  • The winners’ 10-minute oral presentations will take place during the networking drinks on day 2 

The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the NextGen Biomed series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.

The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights. 

LevitasBio

Highly relevant attendees which were encouraged to engage with vendors. I felt supported throughput the entire process.


Technical Account Manager
Levitasbio

Quantabio_logo

Really well organised event with a very supportive, present and friendly Oxford Global team.

Sales Specialist- UK, IR & Nordics
Quantabio

Agilent_Logo_Tag_v_RGB

 

Well organised with a good audience. Nice set up area for exhibitors.


Market Specialist
Agilent

Scienion_Logo

Fantastic conference, the Oxford Global staff are great.


Sales Manager UK and Ireland

Scienion

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Interested in NextGen Omics & Data 2025?